Clinical Trials
3 trialsNCT03225547 2025-12-23
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
University of Chicago
Phase 2 Terminated
NCT02788981 2025-06-10
Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
University of Chicago
Phase 2 Active not recruiting
NCT05062174 2022-12-15
Breast Cancer BRCA1 Carriers: a Pilot Study
Indiana University
Withdrawn